A detailed history of Israel Englander (Millennium Management LLC) transactions in Annexon, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 72,655 shares of ANNX stock, worth $375,626. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72,655
Previous 347,212 79.07%
Holding current value
$375,626
Previous $1.7 Million 74.72%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.49 - $7.2 $1.23 Million - $1.98 Million
-274,557 Reduced 79.07%
72,655 $430,000
Q2 2024

Aug 14, 2024

SELL
$4.33 - $6.79 $4.03 Million - $6.32 Million
-930,976 Reduced 72.84%
347,212 $1.7 Million
Q1 2024

May 15, 2024

BUY
$4.03 - $7.81 $1.88 Million - $3.65 Million
467,169 Added 57.6%
1,278,188 $9.16 Million
Q4 2023

Feb 14, 2024

BUY
$1.63 - $4.63 $314,893 - $894,451
193,186 Added 31.27%
811,019 $3.68 Million
Q2 2023

Aug 14, 2023

SELL
$2.1 - $6.37 $1.57 Million - $4.76 Million
-746,510 Reduced 54.72%
617,833 $2.17 Million
Q1 2023

May 15, 2023

BUY
$3.74 - $7.46 $3.13 Million - $6.25 Million
837,812 Added 159.12%
1,364,343 $5.25 Million
Q4 2022

Feb 14, 2023

SELL
$4.56 - $6.61 $99,777 - $144,633
-21,881 Reduced 3.99%
526,531 $2.72 Million
Q3 2022

Nov 14, 2022

BUY
$3.75 - $6.63 $526,548 - $930,938
140,413 Added 34.42%
548,412 $3.39 Million

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $246M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.